Revvity Blog
Powering innovation from discovery to cure.
Latest
How conditional bispecific antibodies are advancing precision immunotherapy.
Cancer
August 14, 2025 - 2 min read
Cancer
Scaling up oligonucleotide discovery: accelerating therapeutic lead identification from months to weeks.
August 6, 2025 -
3 min read
NGS, Cancer, Precision Medicine
Cell-free DNA: dynamic regulation and NGS strategies for ultra-low-frequency variant detection.
July 28, 2025 -
7 min read
Cancer, Infectious Disease Research
Good gut feelings about the health of microbial research.
June 23, 2025 -
3 min read
NGS, Cancer
Small RNA biomarkers in cancer: how NGS is revolutionizing miRNA-based research.
May 1, 2025 -
6 min read
Cancer
Clonal cell lines or pool cell populations? Choosing the right solution to help avoid inconsistent results.
April 15, 2025 -
2 min read
Cancer
The mixed lymphocyte reaction (MLR): a classic assay for modern drug immune assessment.
March 25, 2025 -
3 min read
Cancer
Utilizing AlphaLISA technology to elucidate CDK2 signaling pathways in CCNE-1 amplified ovarian cancer.
March 5, 2025 -
8 min read
Cancer
How Mimix™ Reference Standards are generated, and how they can support your oncology research.
February 28, 2025 -
7 min read
Cancer
Lentiviral sgRNA CRISPR screening in primary human immune cells.
February 19, 2025 -
2 min read
Cancer
Considerations for engineering a successful knockout cell line generation.
January 17, 2025 -
2 min read